Asia Pacific Sclerotherapy Market Size & Outlook, 2020-2027
Asia Pacific sclerotherapy market, 2016-2027 (US$M)
Related Markets
Asia Pacific sclerotherapy market highlights
- The Asia Pacific sclerotherapy market generated a revenue of USD 199.9 million in 2020.
- The market is expected to grow at a CAGR of 7% from 2021 to 2027.
- In terms of segment, detergents was the largest revenue generating agent in 2020.
- Detergents is the most lucrative agent segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2027.
Asia Pacific data book summary
| Market revenue in 2020 | USD 199.9 million |
| Market revenue in 2027 | USD 320.1 million |
| Growth rate | 7% (CAGR from 2020 to 2027) |
| Largest segment | Detergents |
| Fastest growing segment | Detergents |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Detergents, Chemical Irritants, Osmotic Agents |
| Key market players worldwide | B2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.0% of the global sclerotherapy market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 320.1 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sclerotherapy Market Scope
Sclerotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific sclerotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.
Detergents was the largest segment with a revenue share of 42.22% in 2020. Horizon Databook has segmented the Asia Pacific sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2016 to 2027.
The Asia Pacific region is expected to exhibit highest growth owing to well-developed healthcare infrastructure in Japan and ongoing development in India and China. In addition, aging population is also a significant growth driver for the regional market.
According to World Bank data, the number of individuals aged 65 years and above in East Asia and Pacific region is estimated to rise by around 22.0% every 5 years in East Asia between 2015 and 2034. Asian countries are densely populated and the number of individuals in the geriatric population segment is also surging.
With increase in elderly population the incidence rate of conditions like varicose veins is also high thereby contributing to the regional growth. Countries like China, India and Japan have high acceptance of advanced technologies and thereby the adoption of foam sclerotherapy and thermal ablation procedures is quite high.
Reasons to subscribe to Asia Pacific sclerotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific sclerotherapy market databook
-
Our clientele includes a mix of sclerotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific sclerotherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific sclerotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific sclerotherapy market size, by country, 2016-2027 (US$M)
Asia Pacific Sclerotherapy Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
